Skip to main content
ORTHOPEDIATRICS CORP logo

ORTHOPEDIATRICS CORP — Investor Relations & Filings

Ticker · KIDS ISIN · US68752L1008 LEI · 5493000KUTPFGOPAT717 US Manufacturing
Open in API
Filings indexed 531 across all filing types
Latest filing 2018-11-01 Capital/Financing Update
Country US United States of America
Listing US KIDS

About ORTHOPEDIATRICS CORP

https://www.orthopediatrics.com/

OrthoPediatrics Corp. is a medical device company that designs, develops, and commercializes orthopedic implants and instruments exclusively for the pediatric market. The company provides a comprehensive portfolio of products engineered to address the specific anatomical needs of children with orthopedic conditions and injuries. Its offerings serve key categories within pediatric orthopedics, including trauma, deformity correction, and specialty bracing. OrthoPediatrics focuses on providing surgeons with specialized solutions to improve the lives of young patients.

Recent filings

Filing Released Lang Actions
S-3 Filing
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 registration statement filed with the SEC, which is used by companies to register securities for sale to the public. It includes detailed information about the securities to be offered, including common stock, preferred stock, debt securities, and warrants, as well as the terms of the offering and the plan of distribution. This type of filing is related to capital raising activities and financing updates rather than financial performance reports, management changes, or other categories. Therefore, it fits the definition of a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, so it is not RPA or RNS. Hence, the correct classification is CAP with high confidence.
2018-11-01 English
10-Q Filing
Interim / Quarterly Report Q3 2018
2018-10-31 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The key section is Item 2.02, which states the company issued a press release announcing earnings for the quarter ended September 30, 2018, and includes unaudited condensed consolidated financial statements. The document itself is a short filing (3458 characters) that primarily furnishes the press release as an exhibit and does not contain the full financial report or detailed financial analysis. According to the 'Menu vs Meal' rule, this is an announcement of earnings results rather than the earnings release itself. Therefore, it should be classified as Regulatory Filings (RNS), which is the fallback for such filings that do not contain the full report but announce or furnish it.
2018-10-31 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 19, 2018. It announces FDA clearance for a new surgical system and includes a press release as an exhibit. The document is short (3350 characters) and primarily serves as a disclosure of a material event rather than a detailed financial report or earnings release. It does not contain financial statements or detailed financial analysis. The content fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like Earnings Release or Capital/Financing Update. Therefore, the appropriate classification is Regulatory Filings (RNS).
2018-10-19 English
4 Filing
Director's Dealing
2018-09-14 English
4 Filing
Director's Dealing
2018-09-06 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.